According to Cinda Biotech, recently, Cinda Biotech's Suzhou industrialization base successfully passed the European Medicines Agency's on-site GMP inspection once and officially obtained the EU GMP certificate. This on-site inspection covered the core modules of the entire process, including quality management systems, cell bank management, stock solution and formulation production, plant facilities and equipment, QC laboratories, material storage, computerized systems and data integrity, verification management, and supply chain control.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.